Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 11 to 20 of 40 resources

  • HCV Action good practice case study: Developing patient-centred care in Inverclyde and Renfrewshire
    Inverclyde, in west central Scotland, has the highest estimated prevalence of problem drug use in Scotland (3.2% compared to a national average of 1.58%), while neighbouring Renfrewshire has the fourth highest in Scotland (2.41%). Both areas (which have above-average rates of deprivation) also have high hepatitis C prevalence rates, with many of those with the virus unaware of it.
    UK, Scotland Nov 2015 Case study PDF
  • HCV Action good practice case study: Positive Help support services
    This good practice case study looks at the support services offered to people with hepatitis C in the Lothians by Positive Help. These services include a transport service which allows service users to attend appointments and stay engaged in the care pathway, as well as a service providing domestic help in service users' homes.

    This case study details why the services were established, how they work, and the outcomes that they have achieved.
    UK, Scotland Apr 2016 Case study PDF
  • HCV Action good practice case study: Waverley Care Self Management Programme
    This good practice case study looks at the Waverley Care Self Management Programme. The programme involves the delivery of workshops to people with hepatitis C, which focus on issues such as self-identity, confidence, self-esteem, goal setting and problem solving, with the aim of supporting people with hepatitis C to make informed choices regarding their lifestyle choices and improve the knowledge that they have of their condition.

    The case study explains details why the programme was established, how it works, and the outcomes that it has achieved.
    UK, Scotland Apr 2016 Case study PDF
  • HCV Action good practice case study: Widening access to treatment for PWIDs in Tayside
    This HCV Action good practice case study looks at the Tayside Hepatitis C Managed Care Network (MCN), and its work in making testing and treatment as accessible as possible to people who inject drugs. Established in 2004, the MCN has introduced a number of highly effective facets to its referral and treatment pathway, including the use of non-medical referrals, outreach clinics, and the roll-out of dry blood spot testing in non-clinical settings. It acts as an excellent example of how to respond to the particular needs of cohorts who can often find it difficult to access services.
    UK, Scotland Nov 2014 Case study PDF
  • HCV Action good practice film: Addaction workforce development programme
    In this good practice film, HCV Action interviews David Badcock of Addaction and Stuart Smith of The Hepatitis C Trust, about the development and implementation of an Addaction workforce development programme, which aimed to improve awareness and knowledge of hepatitis C among Addaction staff. The programme was formed as a result of a partnership between Addaction and The Hepatitis C Trust, and involved the secondment of Stuart Smith, National Drug Services Lead at The Hepatitis C Trust, to Addaction to develop and deliver training to Addaction staff.
    UK, England, Scotland, Wales, Greater London Jan 2015 Case study, Training Video
  • HCV Action roadshow "Tackling Hepatitis C in Scottish Prisons", Glasgow: Presentations
    On 6th December 2018, HCV Action held a roadshow in Glasgow focused on tackling hepatitis C in prisons. The event was attended by prison healthcare staff, public health professionals, third sector staff working with prisons or BBVs, and patients. Slides presented on the day are enclosed.
    Scotland 20 Dec 2018 Tools & Templates PDF
  • HCV Action webinar: Hepatitis C services in Scotland during and beyond Covid-19
    With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in Scotland and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. The webinar featured contributions from the following speakers: Professor John Dillon - Clinical Lead for Blood Borne Viruses, NHS Tayside Leon Wylie - Lead Officer, Hepatitis Scotland Rachel Halford - CEO, The Hepatitis C Trust
    Scotland 05 Aug 2020 Training, Tools & Templates, Strategy & Planning Video
  • Hepatitis C Action Plan for Scotland Phase II: May 2008 – March 2011
    The Phase II Hepatitis C Action Plan follows the Scottish Government's first Hepatitis C Action Plan, published in September 2006. A significant strand of the plan is about improving testing, treatment, care and support services for those infected, with a major emphasis placed on increasing the number of people receiving treatment. The plan also recognises and addresses the social care needs and drug addiction problems of infected persons through actions aimed at improving links between clinical, addiction and mental health services.
    Scotland May 2008 Reports & Research, Strategy & Planning PDF
  • Hepatitis C Prevalence and Incidence among Scottish Prisoners and Staff Views of its Management: Final Report
    This report aims to generate reliable data on prevalence and incidence of hepatitis C to inform the Scottish Prison Service and the NHS to develop effective needs-led interventions for hepatitis C (HCV) infected prisoners, and to enable an informed assessment of the effectiveness of measures to prevent the spread of blood borne viruses, especially hepatitis C, within the prison setting, as outlined in the Hepatitis C (Phase (II)) Action Plan for Scotland (2008).
    England, Scotland May 2012 Reports & Research PDF
  • Hepatitis C: interventions for patient case-finding and linkage to care
    Published in July 2019 this review summarizes the evidence for interventions to increase case-finding and linkage to care for hepatitis C-infected patients, in order to support commissioning and provision of evidence-based interventions as part of efforts to achieve hepatitis C (HCV) elimination as a major public health threat in the UK.
    UK, England, Northern Ireland, Scotland, Wales 30 Jul 2019 Reports & Research PDF